Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.
about
Cancers of unknown primary origin: current perspectives and future therapeutic strategiesA mini review on cancer of unknown primary site: A clinical puzzle for the oncologistsEvaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysisImmunohistochemical profile for unknown primary adenocarcinoma.Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study.Patients with cancer of unknown primary: a retrospective analysis of 223 patients with adenocarcinoma or undifferentiated carcinomaClinical guideline SEOM: cancer of unknown primary site.Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.Multiple treatment comparison meta-analyses: a step forward into complexity.Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case reportA patient with profound weight loss after gastric bypass surgery: A case report.Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic reviewA multiple cavity malignancy involving the renal capsule, pleura and meninges: A case report and review of the literature.Occult primary breast cancer at a comprehensive cancer center.Inflammation as a validated prognostic determinant in carcinoma of unknown primary siteGeographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.Cancer of unknown primary site: 20 questions to be answered.Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches.Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.Rapid reduction in the incidence of cancer of unknown primary. A population-based study.Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.The yield and cost of colonoscopy in patients with metastatic cancer of unknown primary.Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.
P2860
Q21245496-4B2DA68C-743E-4922-97C2-CDEEFAC619E1Q26800019-276A008F-5EA5-4C09-98FF-E335C1448472Q26824087-4B75044C-20E2-4913-9FFF-923E09168390Q31047832-D35D0CAF-06EA-4054-B0AA-96EBB06E8E14Q33655046-019E57CD-BBA1-47CA-B9EF-081E478E1077Q34142198-C1B2DA4A-C3D6-4E99-BA52-9EA789D455B3Q34296799-25A6FC89-C6DA-4664-84B7-47C49A0757CAQ34553425-6FFBDE94-E59F-44B5-B83A-E4D9EED1928CQ35068021-7DDE895F-DEC4-4E01-AAFF-1E007578392DQ35089776-979658A5-C857-4451-8132-98EAA39CA4DAQ36086049-ACEDF429-887D-4213-8319-4B43F6820433Q36871377-9D4B768F-310B-4573-86F5-0BEDB080A705Q37029967-FD9C7770-6D16-4691-B8B6-7EFCE5930BB6Q37211740-0BF9B8DA-6421-4024-9268-0399984A4464Q37315777-CB33AA79-69AF-4DFB-98D0-C31272C52459Q37459607-2351DBBE-4D7D-40B6-824D-2822F8D11DFAQ37579558-296D2AB6-2C5F-4980-A426-66436C411505Q37799943-8F3DC723-D0EB-498E-ABC6-9EF186CAB8F8Q37950284-760E7D07-911B-4FC1-8735-C7FCB90F2171Q39412970-EC504EAD-9131-4A21-A554-D6AF4C7DB4C4Q45079647-474B3718-38FC-404E-AEE9-7FCE4D0D8B94Q46296816-8C236C9C-82E4-400C-A0BC-A4C6211E8E0CQ46646232-346CB246-22EF-452B-9019-7705BEE41414Q47654327-97126DD8-8B68-4A0E-9D82-1DFD52671097Q49578351-C32D09BA-8FBF-4F26-B244-0BB74BAB3A35Q54515534-D196AE10-ED46-4B93-BDCE-AC9CEA6E547E
P2860
Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparative survival with dive ...... iple-treatments meta-analysis.
@ast
Comparative survival with dive ...... iple-treatments meta-analysis.
@en
type
label
Comparative survival with dive ...... iple-treatments meta-analysis.
@ast
Comparative survival with dive ...... iple-treatments meta-analysis.
@en
prefLabel
Comparative survival with dive ...... iple-treatments meta-analysis.
@ast
Comparative survival with dive ...... iple-treatments meta-analysis.
@en
P2093
P1476
Comparative survival with dive ...... iple-treatments meta-analysis.
@en
P2093
Andreas D Nearchou
George Pentheroudakis
Nicholas Pavlidis
Vassilis Golfinopoulos
P304
P356
10.1016/J.CTRV.2009.05.005
P577
2009-06-17T00:00:00Z